Citrate, which reduces the expression of Mcl-1, dramatically increases cell death in chemoresistant human ovarian carcinoma cell lines exposed to interfering RNA targeting Bcl-xL or ABT-737. The gene discussed is MCL1; the disease is ovarian carcinoma.